KMTS logo

KESTRA MEDICAL TECHNOLOGIES

KMTSNASDAQ
πŸ† #1994 by market capEarnings Dec 11US Equity
$29.87β–Ό $0.12 (βˆ’0.40%)
πŸŒ… Pre-market$30.20β–² 1.10%Regular close Β· extended-hours price shown
πŸ””
Track KMTS
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 0.4%
7dβ–² 5.6%
14dβ–² 4.3%
30dβ–² 5.0%
ytdβ–² 12.6%
1yβ–² 7.0%
🏦Market Cap
$1.78B
Small Cap
πŸ“ˆRevenue Growth (YoY)
60.7%
High Growth
πŸ“ŠGross Margin
53.9%
Healthy
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
16.7x
Expensive
Otter Score
64
Fair

Trading Snapshot

Day Range
$29.51 – $31.02
52-Week Range
$17.34 – $30.42
Volume (shares)
538,329
Avg Volume (shares)
β€”
Shares Outstanding
59.6M
Next Earnings
2026-12-11

Fundamentals Snapshot

Annual Revenue
$95M
Last Q Revenue
$31M
P/E Ratio
β€”
P/S Ratio
16.7x
EPS (TTM)
$-2.67
Dividend Yield
β€”
Dilution (1yr)
+14.0%
KMTS logo

KESTRA MEDICAL TECHNOLOGIES

KMTS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$95Mβ–² +59.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
51.4%β–² +26.9% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$135Mβ–² +26.7% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$117Mβ–² +15.2% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
58.6Mβ–² +14.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$8Mβ–Ό βˆ’$139M YoY
StockOtter Β· stockotter.space

About KESTRA MEDICAL TECHNOLOGIES

Kestra Medical Technologies, Ltd. operates at the intersection of wearable medical technology and digital healthcare. Its core mission is to revolutionize patient outcomes in cardiovascular disease through intelligent, intuitive, and connected monitoring and therapeutic intervention solutions. The company's flagship offering is the Cardiac Recovery System (CRS) platform, which it develops and commercializes. This unified solution seamlessly integrates cardiac monitoring, therapeutic treatment, digital health capabilities, and patient support services. A central component of the CRS is the ASSURE WCD, a wearable cardioverter defibrillator specifically engineered to protect individuals at elevated risk of sudden cardiac arrest (SCA). Beyond its hardware, the CRS platform also encompasses a suite of integrated digital solutions and services. These are designed to foster enhanced engagement and oversight between patients and healthcare providers, ultimately striving for improved patient well-being. Founded in 2014, the company is headquartered in Kirkland, Washington.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
64/100

Analyst Ratings

β“˜
Consensus
Buy
14 analysts
Strong Buy6
Buy6
Hold2
Sell0
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

Defense WorldΒ·17d ago

Comparing Kestra Medical Technologies (NASDAQ:KMTS) & Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ: BVS - Get Free Report) and Kestra Medical Technologies (NASDAQ: KMTS - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies base

Defense WorldΒ·28d ago

Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Up – Should You Buy?

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS - Get Free Report) shares gapped up prior to trading on Tuesday. The stock had previously closed at $27.14, but opened at $28.48. Kestra Medical Technologies shares last tr

GlobeNewsWireΒ·28d ago

Kestra Medical Technologies Earns Five-Star Rating on Newsweek's List of America's Greatest Mid-Market Companies

KIRKLAND, Wash., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, has earned a five-star rating on Newsweek's list of A

Seeking AlphaΒ·Sep 16

Kestra Medical: Strong Scaling Story, But Profitability Still On The Horizon

Kestra Medical Technologies is transitioning into a high-growth, high-quality medtech platform with 60% YoY revenue growth and expanding gross margins. KMTS targets mid-70s gross margins within 2–3 years, driven by impro

Defense WorldΒ·Sep 16

Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Down After Earnings Miss

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS - Get Free Report)'s share price gapped down before the market opened on Tuesday following a dissappointing earnings announcement. The stock had previously closed at $24.06

BenzingaΒ·Sep 15

Kestra Medical Technologies Posts Mixed Q1 Results, Joins Enova International, Dave and Buster's And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures falling around 200 points on Tuesday.